-

APASL President Doctor Shuichiro Shiina Invites You to Attend the 2024 the Asian Pacific Association for the Study of the Liver Conference in Kyoto, Japan
At the 58th European Association for the Study of the Liver (EASL) Annual Meeting, also known as EASL 2023 Congress, Professor Shuichiro Shiina, the President of the Asian Pacific Association for the Study of the Liver (APASL) and a professor of gastroenterology at Juntendo University in Japan, was invited to attend the conference. He engaged…
-

Interview with Dr. Girard Deciphers at ELCC 2023
The 2023 European Lung Cancer Congress (ELCC) was held from March 29th to April 1st, in a combined online and offline format in Copenhagen, Denmark. Professor Nicolas Girard from the Curie Institute in Paris, France, presented the 3-year data update (Abstract 84O) of the CheckMate 816 study on neoadjuvant immune combined with chemotherapy in the…
-

2023 SGBCC Expert Voting: Radiotherapy
The 18th St.Gallen International Breast Cancer Conference (SGBCC 2023) took place in Vienna, known as the “City of Music”, from March 15th to 18th, 2023, local time. SGBCC brought together breast cancer opinion leaders from all over the world to discuss and vote on the most cutting-edge and controversial topics regarding early-stage breast cancer treatment.…
-

2023 SGBCC Expert Voting: Endocrine Therapy and Chemotherapy Decision for ER-Positive Breast Cancer
The 18th St.Gallen International Breast Cancer Conference (SGBCC 2023) was held in Vienna, the “World Music Capital,” from March 15 to 18, 2023. SGBCC gathered breast cancer opinion leaders from around the world to discuss and vote on the most cutting-edge and controversial topics in early breast cancer diagnosis and treatment, forming an updated St.Gallen…
-

2023 SGBCC Expert Voting: Pathology, Genes, DCIS, Male Breast Cancer
The 18th St.Gallen International Breast Cancer Conference (SGBCC 2023) was held in Vienna, the “City of Music”, from March 15 to 18, 2023 local time. SGBCC gathered breast cancer opinion leaders from all over the world to discuss and vote on the most cutting-edge and controversial topics related to early-stage breast cancer treatment. This forms…
-

2023 SGBCC Expert Voting: HER2 Positive, BRCA Associated, Bone Modifying Therapy, Molecular Diagnosis
The 18th St.Gallen International Breast Cancer Conference (SGBCC 2023) was held in Vienna, known as the “Capital of World Music”, from March 15th to 18th, 2023 local time. On the last day of the conference, the highlight was the expert voting session. Oncology Frontier has compiled expert voting on the treatment of HER2 positive breast…
-

WCLC 2023 : Dr. Wu Yilong, Dr. Cheng Ying, and Dr.Han Baohui Discuss the latest advancements in Small Cell Lung Cancer Research and Analyze the Development of ADC
On the final day of the 2023 World Conference on Lung Cancer (WCLC) , Oncology Frontier had the privilege of interviewing Dr. Wu Yilong from Guangdong Provincial People’s Hospital, Dr. Cheng Ying from Jilin Cancer Hospital, and Dr. Han Baohui from Shanghai Chest Hospital. These three experts participated in a dialogue and discussion regarding hot…
-

WCLC 2023 | Dr. Liu: Immunotherapy Combined Chemotherapy Can Bring Long-term Survival Benefits to ES-SCLC Patients
The 2023 World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer (IASLC), took place in Singapore from September 9th to 12th. Dr. Stephen V. Liu from Georgetown University presented an important study (Abstract No: OA01.04) on the long-term follow-up results of first-line immunotherapy combined with chemotherapy in…